1.Detection the CD44v5 in serum for screening ESCC through ELISA
Xingming WANG ; Hongjiang WANG ; Yuan ZAHNG ; Yongtao WANG
The Journal of Practical Medicine 2015;31(14):2248-2252
Objective To detect the expression of CD44v5 in esophageal squamous carcinoma (ESCC) and analyze its relationship with clinical pathological features,so as to explore the value of detecting CD44v5 in serum for screening ESCC. Methods The CD44v5mRNA and protein in ESCC tissues and its corresponding adjacent non-carcinomatous tissues were detected by RT-PCR and Western-Blot. Enzyme-linked immunosorbent assay (ELISA) was applied to detect the protein in serum of 100 ESCC patients and 60 healthy subjects. Results (1)The expression of CD44v5 in esophageal squamous carcinoma tissues is higher than the tissue adjacent to carcinoma, and CD44v5 expression in different TNM stages, invasion depth, presence of lymph node metastasis and differentiation is with statistical differences(P < 0.05). (2)CD44v5 proteins in patients with ESCC (31.308 ± 10.123) μg/L is higher than healthy subjects (19.364 ± 1.680) μg/L, the difference is statistically significant (P < 0.01). (3)In the trial of using ELISA method to detect CD44v5 content in serum in the diagnosis of ESCC, the area under the ROC curve is 0.865. If the healthy subjects' serum content of the upper limit of 95%confidence interval was taken as a positive judgment standard, the diagnosis effect: sensitivity is 91.0%and speciality is 60.0%. Conclusion The expression of CD44v5 was related to the occurrence and lymph node metastasis of ESCC. Using ELISA method to detect the contents of CD44v5 proteins in serum, with a high sensitivity, can be used to screen ESCC.
2.Combination of kidney transplantation with hematopoietic stem cell infusion
Yongchao GE ; Zhiyu WANG ; Xiaowu ZHAO ; Shuyi WU ; Li ZAHNG ; Jinshun FENG ; Kun DUAN ; Shilin CHEN ; Quanxi GUO ; Tao ZHENG ; Baodong CHANG ; Zhihao YUAN ; Fen QIN
Chinese Journal of General Practitioners 2012;(12):934-936
Ninety six female patients with chronic renal failure were randomly allocated into combination group (n =48) and control group (n =48).In combination group patients received both kidney transplantation and hematopoietic stem cell infusion,in control group patients underwent kidney transplantation only.The results showed that chronic rejection in the combination group was lower than that in the control group [2%(1/48)vs.17% (8/48),P<0.05)].The 1-,3-,5-and 10 y-survival rates of kidney in the combination group were 98% (47/48),94% (45/48),83% (34/41) and 9/17,respectively,those in control group were 98% (47/48),90% (43/48),76% (31/41) and 7/17,respectively.Infusion of donor hematopoietic stem cells can augment chimerism in early postoperative period and significantly reduce the rate of graft rejection,which is beneficial for the quality of life of the recipients.
3.Assessment of the effects of Radix bupleuri and vinegar-baked Radix bupleuri on cytochrome 450 activity by a six-drug cocktail approach.
Ying CHENG ; Yin HUANG ; Yuan TIAN ; Lei XU ; Guo-Qiang LIU ; Zun-Jian ZAHNG
Chinese Journal of Natural Medicines (English Ed.) 2013;11(3):302-308
AIM:
To assess the effects of Radix Bupleuri and vinegar-baked Radix Bupleuri on cytochrome 450 activity of rats.
METHODS:
Six probe drugs (caffeine, midazolam, dextromethorphan, tolbutamide, omeprazole, chlorzoxazone) were simultaneously given to rats after different dosing of Radix Bupleuri or vinegar-baked Radix Bupleuri for seven days. The plasma concentrations of the six probes were measured by high performance liquid chromatography-triple quadrupole mass spectrometry (HPLC-MS/MS) and their corresponding pharmacokinetic parameters were calculated.
RESULTS:
The AUC and T1/2 of midazolam, dextromethorphan and chlorzoxazone decreased significantly (P < 0.05) in rats after different dosing of Radix Bupleuri or vinegar-baked Radix Bupleuri for seven days. Treatment of Radix Bupleuri decreased T1/2 and AUC of omeprazole, but treatment of vinegar-baked Radix Bupleuri with normal dose did not change the pharmacokinetics of omeprazole. The pharmacokinetics of tolbutamide in all vinegar-baked Radix Bupleuri-treated rats showed no statistically significant difference (P > 0.05) from that of controlled rats, however, treatment of Radix Bupleuri decreased tolbutamide T1/2. The pharmacokinetics of caffeine in all Radix Bupleuri or vinegar-baked Radix Bupleuri-treated rats showed no statistically significant difference (P > 0.05) from that of controlled rats.
CONCLUSION
The Radix Bupleuri and vinegar-baked Radix Bupleuri have different effects on the CYP2C9 and CYP2C19. Radix Bupleuri and vinegar-baked Radix Bupleuri have strong induction effects on the CYP2E1, CYP2D6 and CYP3A4, however, have no impact on CYP1A2. The reason of different therapeutic effects of Radix Bupleuri and vinegar-baked Radix Bupleuri extract may be the different effects of Radix Bupleuri and vinegar-baked Radix Bupleuri on the CYP2C9 and CYP2C19.
Animals
;
Bupleurum
;
chemistry
;
Chemistry, Pharmaceutical
;
Cytochrome P-450 Enzyme Inhibitors
;
Cytochrome P-450 Enzyme System
;
chemistry
;
metabolism
;
Drugs, Chinese Herbal
;
chemistry
;
pharmacokinetics
;
Enzyme Inhibitors
;
chemistry
;
pharmacokinetics
;
Kinetics
;
Male
;
Mass Spectrometry
;
Rats
;
Rats, Sprague-Dawley
4.Clinical features and COMP gene mutation in a family with a pseudoachondroplasia child.
Chun-Ting LU ; Li GUO ; Zhan-Hui ZAHNG ; Wei-Xia LIN ; Yuan-Zong SONG ; Lie FENG
Chinese Journal of Contemporary Pediatrics 2013;15(11):937-941
This study aimed to report the clinical characteristics and COMP gene mutation of a family with pseudoachondroplasia (PSACH), a relatively rare spinal and epiphyseal dysplasia that is inherited as an autosomal dominant trait. Clinical information on a 5-year-2-month-old PSACH child and his parents was collected and analyzed. Diagnosis was confirmed by PCR amplification and direct sequencing of all the 19 exons and their flanking sequences of COMP gene, and the mutation was further ascertained by cloning analysis of exon 10. The child presented with short and stubby fingers, bow leg, short limb dwarfism and metaphysic broadening in long bone as well as lumbar lordosis. A mutation c.1048_1116del (p.Asn350_Asp372del) in exon 10, inherited from his father who did not demonstrate any phenotypic feature of PSACH, was detected in the child. PSACH was diagnosed definitively by means of COMP mutation analysis, on the basis of the child's clinical and imaging features. The non-penetrance phenomenon of COMP mutation was described for the first time in PSACH.
Achondroplasia
;
genetics
;
Cartilage Oligomeric Matrix Protein
;
genetics
;
Child, Preschool
;
Cloning, Molecular
;
Humans
;
Male
;
Mutation